这是用户在 2024-3-24 18:37 为 https://www.galleri.com/ 保存的双语快照页面，由 沉浸式翻译 提供双语支持。了解如何保存？

Go further with cancer screening
进一步进行癌症筛查

Introducing Galleri®, the first-of-its-kind multi-cancer early detection test that looks for a signal shared by 50+ types of cancer with a single blood test.1
介绍 Galleri®，这是一种首创的多癌症早期检测测试，通过一次血液检测寻找 50 多种癌症共有的信号。

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.
Galleri 测试不能检测所有癌症信号，也不能在血液中检测到所有癌症。假阳性和假阴性结果确实会发生。

What is the Galleri test?
Galleri 测试是什么？

Galleri redefines what’s possible. Only 5 cancers have recommended screening tests.2 Using Galleri in addition to these tests can increase the chance of finding cancer early, to allow for earlier treatment.1,3
Galleri 重新定义了可能性。只有 5 种癌症有推荐的筛查测试。使用 Galleri 除了这些测试之外，可以增加早期发现癌症的机会，以便进行更早的治疗。

With a single blood test, Galleri screens for a signal shared by multiple cancers that would otherwise go unnoticed.1,4 If a cancer signal is detected, Galleri predicts the tissue type or organ associated with the cancer signal with 88% accuracy* to help guide follow-up diagnostic testing which may include lab work or imaging to confirm cancer.4
通过一次血液检测，Galleri 可以筛查出多种癌症所共有的信号，否则这些信号可能会被忽视。如果检测到癌症信号，Galleri 可以以 88%的准确率预测与该信号相关的组织类型或器官，以帮助指导后续的诊断测试，可能包括实验室检查或影像学检查来确认癌症。

About Galleri
What cancers does Galleri screen for?

*In the PATHFINDER study, Cancer Signal Origin (CSO) prediction accuracy was 88% for participants with a cancer diagnosis among study participants with a "Cancer Signal Detected" test result.
在 PATHFINDER 研究中，对于具有“检测到癌症信号”测试结果的研究参与者中被诊断为癌症的参与者，癌症信号起源（CSO）的预测准确率为 88%。

Person in purple top with stethoscope holding a Galleri box with a Time Best Inventions 2022 banner flag over the image.

Who is Galleri for?
Galleri 是为谁设计的？

Age is the biggest risk factor for cancer. In fact, adults over age 50 are 13 times more likely to have cancer compared to people under the age of 50.5 Cancer risk increases for everyone as they age regardless of family history—only 5% to 10% of cancers are inherited.5,6
年龄是癌症的最大风险因素。事实上，与 50 岁以下的人相比，50 岁以上的成年人患癌症的可能性要高 13 倍。无论家族史如何，随着年龄增长，每个人患癌症的风险都会增加——只有 5%到 10%的癌症是遗传的。

The Galleri test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older.
Galleri 测试推荐给癌症风险较高的成年人，例如 50 岁或以上的人。

  • The Galleri test is available by prescription only.
    Galleri 测试仅限处方使用。

  • Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
    不建议在怀孕、21 岁以下或正在接受积极癌症治疗的人群中使用 Galleri。

white man with short gray hair in gray top and jeans sitting on a couch in front of an open window with his arm around a blonde woman in blue jumpsuit
a bald Black man in a denim button up shirt talking to his partner in their kitchen, a Black woman wearing black cat eye glasses and a blue and pink striped shirt, with a cup of coffee and a tablet on the counter in front of them

Patients 患者

Patients

I am interested in learning more about the Galleri test
我对了解更多关于 Galleri 测试感兴趣

white male doctor in lab coat and stethoscope sitting behind a desk and talking to a white blonde female patient in a blue striped shirt

Healthcare Providers 医疗服务提供者

Healthcare Providers

I am a healthcare provider interested in offering the Galleri test to my patients
我是一名医疗服务提供者，有兴趣为我的患者提供 Galleri 检测

Black woman in a white polka dot shirt with a tan jacket smiling and sitting at a table with a notebook and pen talking to an Asian woman in a blue and black shirt

Employers 雇主

Employers

I represent an employer interested in offering the Galleri test to my organization’s employees
我代表一家雇主，有兴趣为我所在组织的员工提供 Galleri 测试

group of healthcare professionals talking and sitting at a table in front of a window with tablets and notepads

Health Systems 健康系统

Health Systems

I represent a health system interested in making the Galleri test available to my patient population
我代表一个关注将 Galleri 测试提供给我的患者群体的健康系统

Early detection makes a difference
早期发现有所不同

purple text indicating approximately seventy percent.



Around 70% of cancer deaths* are caused by cancers without recommended screenings.7
大约 70%的癌症死亡*是由没有推荐筛查的癌症引起的。

5 circles with graphics inside indicating breast, color, lung, cervical, and prostate cancers

Today, there are 5 recommended cancer screening tests.2 Adding Galleri helps screen for more cancers, including cancers that do not have recommended screening.1,3
今天，有 5 个推荐的癌症筛查测试。添加 Galleri 可以帮助筛查更多的癌症，包括没有推荐筛查的癌症。

purple text indicating 2x



In a clinical study, Galleri approximately doubled the number of cancers detected with recommended screening.3
在一项临床研究中，Galleri 的使用大约使得检测到的癌症数量增加了一倍。

Why early detection matters

*Assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 43% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years).
假设所有前列腺癌、乳腺癌、宫颈癌和结直肠癌病例都可以进行筛查，并且 43%的肺癌病例可以进行筛查（基于估计的 40 岁以上适合筛查的个体中发生肺癌的比例）。

**For those at risk.
对于那些有风险的人。

Galleri should be used in addition to healthcare provider recommended screening tests.
Galleri 应该与医疗保健提供者推荐的筛查测试一起使用。

How Galleri is changing patients' lives
Galleri 如何改变患者的生活

Share your story
1 / 11

Supported by robust clinical data, Galleri sets the standard for multi-cancer early detection

20,000+ individuals participated in large clinical studies1,4
Explore Galleri Test Performance
Text reading: "GRAIL collaborated with leading cancer institutes to study the Galleri test" followed by logos for the Cleveland Clinic, Dana-Farber Cancer Institute, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Intermountain Healthcare, Icahn School of Medicine at Mount Sinai, Sutter Health, UHN Princess Margaret Cancer Centre, Benoroya Research Institute Virginia Mason, Sarah Cannon, Hartford HealthCare Cancer Institute, The US Oncology Network, Knight Cancer Institute, The Christ Hospital Lindner Research Center

Have more questions?

Please answer the following questions to fill in the appropriate form.

You can also contact us at (833) 694‑2553 or use the chat feature on the bottom-right of this page for additional help.

  1. What describes you best?

  2. What are you looking for?

  3. Fill in the form

    We care about your privacy. Our Privacy Policy

    We care about your privacy. Our Privacy Policy

    We care about your privacy. Our Privacy Policy

    Please login to the Provider Portal if you are already an ordering provider.

    We care about your privacy. Our Privacy Policy

    We care about your privacy. Our Privacy Policy

    If you are a concierge, private, or group practice provider, complete this form instead.

    We care about your privacy. Our Privacy Policy

    We care about your privacy. Our Privacy Policy

    We care about your privacy. Our Privacy Policy

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of ​“No Cancer Signal Detected” does not rule out cancer. A test result of ​“Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI:https://doi.org/10.1016/j.annonc.2021.05.806 IF: 50.5 Q1 .

  2. US Preventive Services Task Force. Recommendations Cancer. Accessed 7Mar2023. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results.

  3. Schrag D, McDonnall CH, Naduld L, et al. PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test. Presentation at European Society of Medical Oncology (ESMO) Congress September 9-13, 2022; Paris, France.

  4. Hubbell E, Venn O, Shanmugam A. Shared Cancer Signal: Evidence from Cross-Training. Presentation at USC Computational Biology Symposium; May 19-21, 2022; Los Angeles, CA.

  5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database Incidence - SEER Research Limited-Field Data, 21 Registries, Nov 2020 Sub (2000-2018) - Linked To County Attributes -Time Dependent (1990-2018) Income/Rurality, 1969-2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021, based on the November 2020 submission. Risk Factor Data on file: American Cancer Society Cancer Prevention Studies II/III.

  6. NIH/National Cancer Institute. Genetic testing for inherited cancer susceptibility syndromes. Accessed 3Mar2023. https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet.

  7. American Cancer Society. Cancer Facts & Figures 2022. Atlanta: American Cancer Society; 2022 https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html. Data on file GA-2021-0065.